Promoter holding
64.27%
IP
Instapill Private Limited - Due diligence report
A 360° intelligence report on Tenshi Kaizen: trust score, financial health, credit view, compliance, directors, growth and distress signals …
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Tenshi Kaizen — 360° Intelligence Report
Generated from MCA filings & public records73/100
Trust Score
Moderate
Tenshi Kaizen is assessed as Moderate with a Trust Score of 73/100. Tenshi Kaizen is an active private limited indian non-government company incorporated in 2007, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.
Report generated on 23 Aug 2026 from the latest processed filings. Instapill Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
73/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
78/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
40/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
25/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 25/100 Caution Indicated
- Negative operating earnings - debt service depends on external support.
- Open charges exceed net worth - secured lenders rank ahead.
- Elevated gearing (D/E 38%).
- Externally credit-rated (BBB-).
Charges position: 8 open (232.46 cr) · 6 satisfied (190.85 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 5 | 48.0 cr |
| Hdfc Bank Limited | 5 | 48.0 cr |
| Yes Bank Limited | 2 | 48.0 cr |
| Karnataka State Financial Corporation | 1 | 48.0 cr |
| Axis Bank Limited | 1 | 48.0 cr |
Compliance Score: 78/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 2 court forum(s).
- Delayed payments to MSME suppliers disclosed (700 disclosure(s)).
- 1 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 90/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ANKIT GUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VENKATARAMAN SUBRAMANIAN IYER | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAJASHRI SANTOSH KUMAR OJHA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| GOPAKUMAR GOPALAN NAIR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| GURUSWAMY PENDYALA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Ankit Gupta | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Gunashekar Karthik | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 7 directors on the board.
- No disqualified or deactivated DINs.
- 3 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Tenshi Pharmaceuticals Private Limited
Subsidiaries
-
Group entities
2
Capital events
30 allotment(s) · 2 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Tenshi Kaizen Bv, Netherlands | Subsidiary Company | 74.00% |
| Tenshi Kaizen Inc,usa | Subsidiary Company | 74.00% |
| Tenshi Kaizen Pharma Canada Ltd | Subsidiary Company | 74.00% |
| Tenshi Kaizen Private Limited, Uk | Subsidiary Company | 74.00% |
| Tenshi Kaizen Usa Inc, Usa | Subsidiary Company | 74.00% |
| Tenshi Pharmaceuticals Private Limited | Holding Company | 74.00% |
| Tenshi Kaizen Pharma Pte. Ltd., Singapore | Subsidiary Company | 74.00% |
| Velbiom Probiotics Private Limited | Associate Company | 74.00% |
| Olene Life Sciences Private Limited | Associate Company | 74.00% |
Key managerial personnel: ANKIT GUPTA (Whole-time director) · GURUSWAMY PENDYALA (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 75 · Distress 75
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
EPFO headcount growing - hiring signal.
Operating for 19+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
8 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 5.55 cr.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence76/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment43/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 8 open charge(s) of 232.46 cr already registered.
- Compliance record supports lending.
Investor view62/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events11 Dec 2025
Charge satisfied
Hdfc Bank Limited
13 Oct 2025
Charge created
Others - 60.00 cr
Charge created
Others - 95.00 cr
09 Oct 2025
Charge created
Others - 10.00 cr
16 Sep 2025
Last AGM held
Annual general meeting
31 Jul 2025
Director appointed
Gunashekar Karthik (Company Secretary)
Charge satisfied
Others
22 Jul 2025
Charge created
Hdfc Bank Limited - 32.21 Lakh
17 Jun 2025
Director appointed
Ankit Gupta (Ceo)
31 Mar 2025
Latest balance sheet
Filed with ROC
11 Feb 2025
Director appointed
ANKIT GUPTA (Whole-time director)
Director appointed
RAJASHRI SANTOSH KUMAR OJHA (Director)
Director appointed
GOPAKUMAR GOPALAN NAIR (Director)
Director ceased
CHAMARAHALLI SUNDHAR KRISHNA IYER
31 Dec 2024
Director ceased
Hanumappa Reddy Bhavana
10
Key Observations
Auto-generated from the data aboveRevenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
7 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of BBB- from Icra.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 30 security allotment(s) - amounts available in the full report.
37 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Modern Insecticides Limited | U24211PB1990PLC010771 | Ludhiana, Punjab, India |
| Datta Hydro-Chem Private Limited | U24110MH1999PTC120629 | Navi Mumbai, Maharashtra, India |
| Goodearth Agrochem Private Limited | U24200MH2005PTC157468 | Nagpur, Maharashtra, India |
| Provet Pharma | U24231TN2009PTC073198 | Chennai, Tamil Nadu, India |
| Kwalichem Private Limited | U24304MH2020PTC349278 | Mumbai, Maharashtra, India |
| Nanavatigroup | U24110GJ1991PLC126454 | Vapi, Gujarat, India |
| Nabros Pharma Private Limited | U24230GJ1983PTC006628 | Ahmadabad City, Gujarat, India |
| Wex Tech | U24231PN2001PTC015940 | Pune, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Tenshi Kaizen before audits and certifications: compliance score 78/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Tenshi Kaizen: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Enhanced diligence advised. Credit risk score 25/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 75/100, margin trends, ownership structure and peer set for Tenshi Kaizen - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 73/100, distress signals and MSME payment-delay disclosures - know whether Tenshi Kaizen pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Tenshi Kaizen - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Tenshi Kaizen an active company?
Tenshi Kaizen has MCA status “Active” with a compliance score of 78/100 (Low Risk).
Is Tenshi Kaizen financially healthy?
Tenshi Kaizen has a Financial Health Score of 40/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Tenshi Kaizen?
Its overall Trust Score is 73/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Tenshi Kaizen?
The ultimate holding entity is Tenshi Pharmaceuticals Private Limited. 7 active director(s) are on record.
Does Tenshi Kaizen have loans or charges against its assets?
8 open charge(s) are registered against its assets, and 6 earlier charge(s) stand satisfied.
Is Tenshi Kaizen up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 78/100 (Low Risk).
Is it risky to lend to Tenshi Kaizen?
Its Credit Risk Score is 25/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
